Citations 0
May 10, 2000

Protection for Human Subjects in Medical Research—Reply

Author Affiliations

Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Contributing EditorIndividualAuthor


Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000

JAMA. 2000;283(18):2387-2390. doi:10.1001/jama.283.18.2387

In Reply: Dr Kaufman indicates that his current IRB is able to devote enough time to provide a careful review of each study that comes before it. This is not inconsistent with the claim that many IRBs are overtaxed. A recent study undertaken for the National Institutes of Health surveyed 491 multiple project assurance IRBs and found that the "49 highest-volume IRBs accounted for 34,500 initial reviews, 34 times more than the 1,000 reviews conducted in the 49 lowest-volume IRBs."1

First Page Preview View Large
First page PDF preview
First page PDF preview